Allegations Made by the Plaintiff
Xarelto Bellwether Trials to Take Place in 2017
Four trials related to Xarelto Bellwether are set to take place in early 2017. The Eastern District of Louisiana currently has 1,710 Xarelto injury lawsuits and the number of serious bleeding problems continues to rise throughout the United States.
Louisiana, Mississippi and Texas Trials
On February 6 and March 13, 2017 the first two Eastern District of Louisiana trials will take place. Mississippi’s trial will take place on April 24, 2017 and the Texas trial will commence on May 30, 2017.
Judge Fallon has ordered that 40 lawsuits will be selected in January 2016. They will be trial-ready and include details from those related to the case including doctors, plaintiffs, physicians and sales reps of the manufacturers of the drug.
Why Use Xarelto?
Xarelto was first introduced in 2011 to replace Coumadin or Warfarin. It prevents blood clots in patients who suffer from deep vein thrombosis, have a risk of getting a stroke through atrial fibrillation or pulmonary embolism. Xarelto is the most used anticoagulant in the United States with annual sales reaching $1 Billion.
Risk of Anticoagulant Bleeding
There is always a risk of bleeding and other health issues from Xarelto and similar blood thinning products. However, Xarelto has caused many serious health problems in patients. In the most severe cases it has resulted in the death of patients.
It is advertised as an easy-to-use product but its safety is questioned. The effects of Xarelto cannot be reversed, unlike similar products such as Warfarin.
Pradaxa Lawsuits and Settlements